$VNRX
VolitionRx Limited ($VNRX) campaign
A first half update: revenue of $1.4 million, up 112% year on year, the Nu.Q NETs assay transferred onto Sysmex's platform, and licensing discussions running with more than a dozen diagnostics and liquid biopsy companies.